ISSN 1671-5411 CN 11-5329/R
Hongcai SHANG, Guohua DAI, Junhua HANG, YaozuXIANG, YangWANG, Junping ZHANG, Wuxun DU, Jingyuan MAO, Boli ZHANG, Chen YAO, Weiliang WENG, Tiancai WEN. Myocardial infarction secondary prevention study (MISPS). J Geriatr Cardiol 2006; 3(2): 116-119.
Citation: Hongcai SHANG, Guohua DAI, Junhua HANG, YaozuXIANG, YangWANG, Junping ZHANG, Wuxun DU, Jingyuan MAO, Boli ZHANG, Chen YAO, Weiliang WENG, Tiancai WEN. Myocardial infarction secondary prevention study (MISPS). J Geriatr Cardiol 2006; 3(2): 116-119.

Myocardial infarction secondary prevention study (MISPS)

  • Publish Date: 2006-06-28
  • Background Traditional Chinese medicine (TCM), especially herbal medicine, has been widely used in China and now is also being increasingly used in other countries for the treatment of cardiovascular diseases. Although many studies have demonstrated that certain Chinese herbal products are effective and safe for the treatment of cardiovascular diseases, most of these lack sufficient quality. Therefore, large randomized clinical trials and further scientific research to determine its safety, effectiveness are necessary. QiShen YiQi Dripping Pills (QSYQDP) is a herbal preparation clinically used in the treatment and prevention of coronary artery disease. Preliminary observations have shown its safety and effectiveness. Methods/Design This randomized, controlled trial will recruit 3600 patients with a history of myocardial infarction. Patients will be randomized into two groups by a Centr-Randomized System. One group receives QSYQDP, the other group receive aspirin. This trial protocol will describe eligibility criteria, detailed information on the treatment definition, blinding, endpoints, statistical methods, sample size determination, data management, legal aspects, and the current status of the trial. Discussion This trial is one of the first randomized, controlled clinical trial to evaluate the efficacy and safety of traditional Chinese herbal medicine in the treatment and secondary prevention of coronary artery disease. The results of this study should help to define the role of TCM in modern medical care, as well as to provide the management strategy for CAD patients in China and other countries.
  • loading
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (2135) PDF downloads(1816) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return